DHR pre-earnings setup: report due 2026-07-21DHR 财报前观察：预计 2026-07-21 发布
Setup Overview
Danaher Corporation (ticker DHR) is scheduled to report Q2 2026 earnings on July 21, 2026, just four trading days following the July 17, 2026 disclosure date. Consensus analyst estimates target $1.83 per share (EPS) and $6.1059 billion in revenue. The company has a $145.1 billion market capitalization, with shares trading at $205.04, marking a 2.1166% daily gain as of July 17.
Report Relevance Context
Danaher has exceeded consensus EPS estimates in each of the two most recent quarters: Q1 2026 actual EPS hit $2.23 versus the $2.16 consensus, while Q4 2025 actual EPS came in at $1.89 versus the $1.72 estimate. Institutional holdings have trended positively: as of December 31, 2025, 2,351 institutional holders held 82.2% of the company’s float, a net increase of 139 holders from prior reporting periods, with total institutional holdings valued at $133.1 billion, including 320 new positions and 1,151 increased positions. Analyst ratings have remained stable since March 2026, with 4 strong buy, 19 buy, and 4 hold ratings, with no sell or strong sell ratings issued.
Cross-Validation Signal
On July 16, 2026—five days ahead of the earnings report—multiple insiders filed Form 4 SEC transaction disclosures: Chief Accounting Officer Christopher Bouda transferred 60 shares via an in-kind transaction at $200.79 per share, for a total value of $12,047. Directors Linda Filler and Elias A. Zerhouni also filed multiple share transfer transactions on the same day.
Follow-up Markers
Investors should verify the following core metrics following the earnings release: actual EPS versus the $1.83 consensus estimate, actual revenue versus the $6.1059 billion consensus, segment-specific performance (notably the diagnostic and research segments), free cash flow, forward guidance, backlog/RPO levels, and margin trends. This signal provides pre-earnings contextual data only and does not predict actual earnings results.
前置事件概况
丹纳赫公司（股票代码DHR）将于2026年7月21日发布2026年第二季度财报，距当前披露日（2026年7月17日）仅4个交易日。市场普遍预期本次财报每股收益（EPS）为1.83美元，营收为61.0592亿美元，公司当前市值为1451亿美元，股价报205.04美元，当日上涨2.1166%。
报告关注度背景
丹纳赫此前连续两个季度超出市场预期：2026年第一季度实际EPS为2.23美元，超出预期的2.16美元；2025年第四季度实际EPS为1.89美元，超出预期的1.72美元。机构持仓方面，截至2025年12月31日，公司共有2351家机构持有者，较此前增加139家，机构持有流通股比例达82.2%，总持仓规模1331亿美元，其中包含320笔新建持仓、1151笔增持持仓。分析师评级自2026年3月以来保持稳定，当前为4个强力买入、19个买入、4个持有评级，无卖出或强力卖出评级。
交叉验证信号
2026年7月16日，即财报发布前5日，多名公司内部人士提交了Form 4 SEC备案文件：首席会计官Christopher Bouda以实物形式转让60股股票，交易价格为200.79美元/股，总价值12047美元；董事Linda Filler和Elias A. Zerhouni也于当日提交了多笔股票转让备案。
后续关注要点
投资者需在财报发布后验证以下核心数据：实际EPS与市场预期1.83美元的偏差、实际营收与61.0592亿美元预期的偏差、各业务板块（如医疗诊断板块）的营收表现、自由现金流、未来业绩指引、订单储备（RPO）及利润率趋势。本信号仅提供财报发布前的市场和备案背景，不代表实际业绩结果。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。